Archives for May 30, 2005

← 2005

Isolagen plays its ACE card

Isolagen unveils its automated cellular expansion (ACE) system, which claims to harvest cells more cost-effectively than other cell harvesting systems currently available. The system will reduce the time needed by research and commercial labs that...

People on the move

In-PharmaTechnologist.com presents its periodic round up of personnel news in the pharmaceutical manufacturing and drug development sectors.

Roche plans new plant to meet Tamiflu demand

Concern over the threat of a new flu pandemic is hiking demand for Roche's Tamiflu >(oseltamivir phosphate) product to the extent that the firm needs to build another production plant, reports Phil Taylor.

Singapore CMO wins second major contract

Singapore contract biologics manufacturer A-Bio has added another top pharmaceutical company to its list of customers, just over 18 months after starting operations, reports Phil Taylor.

Qiagen acquisition extends diagnostics range

Qiagen has acquired the PCR diagnostics company Artus, in a move that now allows Qiagen to offer preanalytical sample preparation and diagnostic assay solutions to its partners in molecular diagnostics. The acquisition further allows Qiagen to...

AES cuts microbial air sampling in cleanroom

France's AES Laboratories has developed a system for the rapid monitoring of air in the cleanroom or pharmaceutical production facility for microbial contamination, without having to wait days for culturing, reports Phil Taylor.

Pfizer signs up for Chromos cell engineering system

Chromos Molecular Systems won another customer for its cell line engineering technology yesterday, when world number one drugmaker Pfizer took out a license for its ACE system, reports Phil Taylor.

Pfizer enters VR1 deal with Renovis

Pfizer has entered a worldwide collaboration and licensing agreement with Renovis to research, develop and commercialise small molecules that target a receptor, which generates signals for certain types of pain.